Macleods Pharmaceuticals Limited
UkraineAll drugs from this manufacturer
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It is used in cases where treatment with individual active substances does not provide adequate blood pressure control.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 5 mg ATC: C09DB02
-
The drug is intended for the treatment of essential hypertension (high blood pressure).
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
-
The drug is intended for the treatment of essential hypertension (high blood pressure).
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
-
The drug is prescribed for the treatment of essential hypertension (high blood pressure) in adults, as well as for the treatment of hypertension in children and adolescents aged 6 to 18 years.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 10 mg ATC: C09CA08
-
The drug is intended for the treatment of high blood pressure (essential hypertension) in adults, as well as for the treatment of hypertension in children and adolescents aged 6 to 18 years.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC: C09CA08
-
The drug is used to treat essential hypertension (high blood pressure) in adults, as well as to treat hypertension in children and adolescents aged 6 to 18 years.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC: C09CA08
-
The drug is used to treat patients with symptoms of osteoarthritis of the hip or knee. It has anti-inflammatory and analgesic effects; however, the effect is not immediate but appears after 2–4 weeks of treatment.
Dosage form: capsules
Active substance Dosage diacerein 50 mg ATC: M01AX21
-
The drug is used to treat reflux esophagitis (associated with GERD), to maintain remission in erosive esophagitis, and to treat pathological conditions accompanied by excessive gastric acid secretion (e.g., Zollinger-Ellison syndrome).
Dosage form: tablets, coated, enteric-coated
Active substance Dosage pantoprazole 40 mg ATC: A02BC02
-
The drug is prescribed to adults for the treatment of pulmonary tuberculosis that is resistant to standard therapy (resistant to isoniazid, rifampicin, fluoroquinolones, and other second-line drugs). It should be used only in combination with bedaquiline and linezolid.
Dosage form: tablets
Active substance Dosage pretomanid 200 mg ATC: J04AK08
-
The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori bacteria in combination with antibiotics.
Dosage form: tablets, coated, enteric-coated
Active substance Dosage rabeprazole 20 mg ATC: A02BC04
-
The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori bacteria in combination with antibacterial agents.
Dosage form: tablets, coated, enteric-coated
Active substance Dosage rabeprazole 10 mg ATC: A02BC04
-
The medicinal product is intended for the treatment of tuberculosis in children weighing less than 25 kg during the continuation phase.
Dosage form: tablets, dispersible
Active substance Dosage rifampicin 75 mg isoniazid 50 mg ATC: J04AM02
-
The drug is intended for the initial phase of tuberculosis treatment in children caused by Mycobacterium tuberculosis, in accordance with WHO guidelines.
Dosage form: tablets, dispersible
Active substance Dosage rifampicin 75 mg isoniazid 50 mg pyrazinamide 150 mg ATC: J04AM05
-
Rifampicin/isoniazid is used for the treatment of pulmonary tuberculosis and extrapulmonary tuberculosis in both the initial and maintenance phases of therapy.
Dosage form: tablets, film-coated
Active substance Dosage rifampicin 150 mg isoniazid 75 mg ATC: J04AM02
-
These medications are prescribed for the acute treatment of the headache phase during migraine attacks (with or without aura) in adults.
Dosage form: tablets
Active substance Dosage rizatriptan 10 mg ATC: N02CC04
-
These medications are prescribed for the acute treatment of the headache phase during migraine attacks (with or without aura) in adults.
Dosage form: tablets
Active substance Dosage rizatriptan 5 mg ATC: N02CC04
-
The drug is used to treat high cholesterol levels (hypercholesterolemia) in adults, adolescents, and children from 6 years of age. It is also used to prevent cardiovascular disorders in high-risk patients.
Dosage form: tablets, film-coated
Active substance Dosage rosuvastatin 5 mg ATC: C10AA07
-
The drug is prescribed for adults, adolescents, and children (from 6 years old) to treat elevated levels of cholesterol and triglycerides. It is also used to prevent cardiovascular disorders in high-risk patients.
Dosage form: tablets, film-coated
Active substance Dosage rosuvastatin 10 mg ATC: C10AA07
-
The drug is used to treat elevated levels of cholesterol and triglycerides in adults, adolescents, and children from 6 years of age. It is also used for the prevention of cardiovascular disorders in high-risk patients.
Dosage form: tablets, film-coated
Active substance Dosage rosuvastatin 20 mg ATC: C10AA07
-
The drug is prescribed for adults, adolescents, and children from 6 years of age to treat elevated cholesterol (hypercholesterolemia) and triglycerides. It is also used to prevent cardiovascular disorders in high-risk patients.
Dosage form: tablets, film-coated
Active substance Dosage rosuvastatin 40 mg ATC: C10AA07
-
The drug is used to treat Alzheimer's disease, ranging from mild to severe forms.
Dosage form: tablets, film-coated
Active substance Dosage memantine 10 mg ATC: N06DX01
-
The drug is prescribed for the treatment of Alzheimer's disease, ranging from mild to severe forms.
Dosage form: tablets, film-coated
Active substance Dosage memantine 20 mg ATC: N06DX01
-
The drug is used for the treatment of influenza, as well as for its prevention after contact with an infected person or during a seasonal epidemic.
Dosage form: capsules, hard
Active substance Dosage oseltamivir 30 mg ATC: J05AH02
-
The drug is used for the treatment of influenza, as well as for its prevention after contact with an infected person or during seasonal epidemics.
Dosage form: capsules, hard
Active substance Dosage oseltamivir 45 mg ATC: J05AH02
-
The drug is used for the treatment of influenza, as well as for its prevention (after contact with a sick person or during a seasonal epidemic) in adults and children from 1 year of age.
Dosage form: capsules, hard
Active substance Dosage oseltamivir 75 mg ATC: J05AH02
-
The drug is used for the treatment of HIV-1 infection in adults and adolescents (from 12 years of age weighing at least 35 kg) as part of combination therapy. It is also indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 sexual transmission in men at risk.
Dosage form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir alafenamide 25 mg ATC: J05AR17
-
The drug is used for the treatment of HIV-1 infection (in combination with other antiretroviral agents) and chronic hepatitis B in adults and adolescents (from 12 to 18 years of age with a body weight of at least 35 kg).
Dosage form: tablets, film-coated
Active substance Dosage tenofovir disoproxil fumarate 300 mg ATC: J05AF07
-
The drug is used in combination therapy for the treatment of adults with HIV-1 infection.
Dosage form: tablets, film-coated
Active substance Dosage tenofovir disoproxil fumarate 300 mg emtricitabine 200 mg ATC: J05AR03
-
The drug is used to stop or prevent bleeding associated with increased fibrinolysis. This may include uterine, gastrointestinal, or nasal bleeding, postoperative bleeding (e.g., after parotid gland surgery, tonsillectomy, or tooth extraction in patients with hemophilia), or in cases of hereditary angioedema.
Dosage form: tablets, film-coated
Active substance Dosage tranexamic acid 250 mg ATC: B02AA02
-
The drug is used to stop bleeding or prevent it in cases of enhanced fibrinolysis. This includes uterine, gastrointestinal, and nasal bleeding, as well as bleeding following certain surgical procedures (e.g., tooth extraction in patients with hemophilia, surgeries on the parotid gland or cervix) and in cases of hereditary angioedema.
Dosage form: tablets, film-coated
Active substance Dosage tranexamic acid 500 mg ATC: B02AA02
-
The drug is used for irritable bowel syndrome and functional gastrointestinal disorders accompanied by abdominal pain, spasms, a feeling of fullness, bloating, constipation, or diarrhea.
Dosage form: tablets, film-coated
Active substance Dosage trimebutine 200 mg ATC: A03AA05
-
The drug is used to treat functional urinary tract disorders occurring in benign prostatic hyperplasia (enlargement of the prostate gland).
Dosage form: capsules, extended-release, hard
Active substance Dosage tamsulosin 0.4 mg ATC: G04CA02
-
The drug is used to treat arterial hypertension (high blood pressure) in adults and children aged 6 to 18 years. It is also prescribed for the treatment of heart failure and for patients in a post-infarction state.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg ATC: C09CA03
-
The drug is used to treat arterial hypertension (high blood pressure) in adults and children aged 6 to 18 years. It is also used for the treatment of heart failure and in the post-myocardial infarction state.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 40 mg ATC: C09CA03
-
The drug is used to treat arterial hypertension (high blood pressure) in adults and children aged 6 to 18 years. It is also used for the treatment of heart failure and in the post-myocardial infarction state.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 80 mg ATC: C09CA03
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults if this condition cannot be controlled by using only one component (amlodipine or valsartan) alone.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg amlodipine 5 mg ATC: C09DB01
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults whose blood pressure is not controlled by a combination of individual drugs.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 12.5 mg amlodipine 10 mg ATC: C09DX01
-
The drug is used to treat arterial hypertension (high blood pressure) in adults and children aged 6 to 18 years. It is also prescribed for the treatment of heart failure and in the post-myocardial infarction state.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg ATC: C09CA03
-
The drug is used for the treatment of essential hypertension (high blood pressure) in adults.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 12.5 mg amlodipine 5 mg ATC: C09DX01
-
The drug is prescribed for the treatment of essential arterial hypertension (high blood pressure) in cases where blood pressure cannot be controlled using a single drug alone.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 12.5 mg ATC: C09DA03
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 12.5 mg amlodipine 5 mg ATC: C09DX01
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 12.5 mg amlodipine 10 mg ATC: C09DX01
-
The drug is prescribed for the treatment of essential arterial hypertension (high blood pressure) in cases where blood pressure cannot be controlled using a single drug alone.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 25 mg ATC: C09DA03
-
The drug is used to treat arterial hypertension (high blood pressure) in adults and children aged 6 to 18 years. It is also used for the treatment of heart failure and in the post-myocardial infarction state.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 320 mg ATC: C09CA03
-
The drug is used to treat arterial hypertension (high blood pressure) in adults and children aged 6 to 18 years. It is also used to treat heart failure and in the post-myocardial infarction state.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 320 mg ATC: C09CA03
-
The drug is prescribed for the treatment of essential arterial hypertension (high blood pressure) in cases where blood pressure cannot be controlled using a single drug alone.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 320 mg hydrochlorothiazide 12.5 mg ATC: C09DA03
-
The drug is prescribed for the treatment of essential arterial hypertension (high blood pressure) in cases where blood pressure cannot be controlled using a single drug alone.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 320 mg hydrochlorothiazide 25 mg ATC: C09DA03
-
The drug is used to treat arterial hypertension (high blood pressure) in adults and children aged 6 to 18 years. It is also prescribed for the treatment of heart failure and in the post-myocardial infarction state.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 40 mg ATC: C09CA03
-
The drug is used to treat arterial hypertension (high blood pressure) in adults and children aged 6 to 18 years. It is also used to treat heart failure and in the post-myocardial infarction state.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 80 mg ATC: C09CA03
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults if this condition cannot be controlled using only one component (amlodipine or valsartan).
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg amlodipine 10 mg ATC: C09DB01